404
Spinal Muscular Atrophy Medicine Market Report
Spinal Muscular Atrophy Medicine Market is segmented by Disease Type (Type 1, Type 2, Type 3, Type 4), by Treatment (Gene therapy, Drug [Spinraza, RG7916, RG6083 (Olesoxime)]), by Route of Administration (Oral, Intrathecal), and Region. It also focuses on the COVID-19 Impact Analysis and Forecast to 2028.